VIPhyb-treated BALB/c mice had 2–3 fold more TNF-α expressing CD8+ T-cells than PBS-treated BALB/c mice (Fig. 7A), while an effect on TNF-α expression was not seen in VIPhyb-treated C57BL/6 mice following mCMV-infection. Here, CD8A is linked to infection.